top
Search terms
Results 1 - 3 of 3 - ordered by :
Epeuropace

Randomized trials in patients with atrial fibrillation (AF) have consistently demonstrated that compared with placebo, adjusted-dose vitamin K antagonists (VKAs) reduce the incidence of stroke by ...

Europace, Editorial, Laurent Fauchier, Gregory Y.H. Lip

Date : 01/06/2010
Ehjournal

Analyses of the Framingham cohort established the independent contribution of non-valvular atrial fibrillation (NVAF) to the risk of stroke and estimated an annual stroke incidence of 4.1%.1 In an ...

European Heart Journal, Cairns, John A.

Date : 07/11/2016 Item size : 161063 bytes
Escardio

Many stroke risk assessment schema classify a large proportion of subjects into the ‘moderate risk’ category where treatment guidelines recommend either warfarin or aspirin, and risk ...

Date : 09/06/2010